Common neurotransmitters include serotonin, epinephrine, dopamine, acetylcholine ... before binding to muscle cells to stimulate movement. Interestingly, during the dreaming stage of sleep ...

Developed by Karuna Therapeutics, recently acquired by Bristol Myers Squibb, Cobenfy diverges from the industry’s dopamine-dominated approach, targeting muscarinic acetylcholine receptors instead.